Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Type of study
Affiliation country
Publication year range
1.
J Diabetes Investig ; 14(5): 707-715, 2023 May.
Article in English | MEDLINE | ID: mdl-36852538

ABSTRACT

AIMS/INTRODUCTION: Equol, which is produced by enteric bacteria from soybean isoflavones, has a chemical structure similar to estrogen. Both in vivo and in vitro studies have shown the beneficial metabolic effects of equol. However, its effects on type 2 diabetes remain unclear. We investigated the association between the equol producers/non-producers and type 2 diabetes. MATERIALS AND METHODS: The participants included 147 patients with type diabetes mellitus aged 70-89 years, and 147 age- and sex-matched controls. To ascertain the equol producers or non-producers, we used the comparative logarithm between the urinary equol and daidzein concentrations (cut-off value -1.75). RESULTS: The urinary equol concentration was significantly lower in the diabetes group compared with the non-diabetes group (P = 0.01). A significant difference in the proportion of equol producers was observed among all participants (38.8% in the diabetes group and 53.1% in the non-diabetes group; P = 0.01). The proportion of equol producers among women was significantly lower in the diabetes group (31.4%) than in the non-diabetes group (52.8%; P < 0.01). Additionally, the frequency of dyslipidemia in female equol producers was significantly lower than that in female non-equol producers (P < 0.01). Among men, no such differences were observed. We found a significant positive correlation between the urinary equol and daidzein concentrations among equol producers (r = 0.55, P < 0.01). CONCLUSIONS: Our study findings showed that postmenopausal women had a low proportion of equol producers with diabetes and dyslipidemia.


Subject(s)
Diabetes Mellitus, Type 2 , Equol , Gastrointestinal Microbiome , Glycine max , Isoflavones , Aged , Female , Humans , Male , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/microbiology , Diabetes Mellitus, Type 2/urine , East Asian People , Equol/metabolism , Equol/urine , Isoflavones/metabolism , Isoflavones/urine , Aged, 80 and over , Gastrointestinal Microbiome/physiology , Glycine max/metabolism , Phytoestrogens/metabolism , Sex Factors , Postmenopause/metabolism , Postmenopause/urine , Dyslipidemias/metabolism , Dyslipidemias/microbiology , Dyslipidemias/urine
2.
Urologiia ; (5): 35-9, 2014.
Article in Russian | MEDLINE | ID: mdl-25807757

ABSTRACT

In patients suffering from urolithiasis, metabolic diagnostics often reveals abnormalities contributing to the formation of stones: hypocitraturia, hyper- and hypocalcemia, hypercalciuria, hypomagnesemia/hypomagnesuria, hyperoxalaturia, etc. Before surgery, complex biochemical examination of blood and 24-hourcollection urine in 82 patients with urolithiasis was performed. The analysis of the main laboratory parameters of carbohydrate, lipid, calcium and phosphorus and purine metabolism found the prevalence of violations of calcium and phosphorus metabolism in these patients. Dyslipidemia was diagnosed in 31 (37.8%) patients. There was a significant positive correlation between serum total cholesterol and serum total calcium (rs = 0.3315, P = 0.0103). Low serum calcium levels were associated with hyperoxalaturia (rs = -0.4270, P = 0.0295). There was a significant effect of natriuria on urinary excretion of oxalate (rs = 0.6107, P = 0.0001), Mg (rs = 0.4156, P = 0.0096) and K (rs = 0.5234, P = 0.00005). The study shows the role of magnesium in the prevention of recurrence and manifestation of urolithiasis. The combination of two or more types of hormonal and metabolic disorders increases the incidence of recurrent stones. Timely correction of hormonal-metabolic status allows to reduce the risk of stone formation, and hospitalization attributable to the complications associated.


Subject(s)
Calcium/metabolism , Dyslipidemias/metabolism , Hyperparathyroidism/metabolism , Phosphorus/metabolism , Urinary Calculi/etiology , Urinary Calculi/metabolism , Adult , Aged , Aged, 80 and over , Blood Glucose/metabolism , Calcium/blood , Calcium/urine , Carbohydrate Metabolism , Dyslipidemias/blood , Dyslipidemias/complications , Dyslipidemias/urine , Female , Humans , Hyperparathyroidism/blood , Hyperparathyroidism/complications , Hyperparathyroidism/urine , Lipid Metabolism , Magnesium/metabolism , Male , Middle Aged , Phosphorus/blood , Phosphorus/urine , Purines/metabolism , Urinary Calculi/blood , Urinary Calculi/urine
SELECTION OF CITATIONS
SEARCH DETAIL